GLW (NYSE: GLW) shareholder plans $3.83M sale of 30,000 shares

Rhea-AI Filing Summary

A shareholder of GLW has filed a notice of intent to sell 30,000 common shares. The planned sale has an aggregate market value of $3,829,994.64 and is to be executed through UBS Financial Services Inc. on the NYSE, with an approximate sale date of 02/09/2026.

The shares to be sold were acquired through restricted stock releases from the issuer on 07/10/2024, 07/10/2025, and 01/15/2026. The filing also notes that the person signing represents they do not know of any undisclosed material adverse information about the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	30000	3829994.64	857360396	02/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	01/15/2026	restricted stock release	issuer			4698	01/15/2026	n/a
common	07/10/2024	restricted stock release	issuer			13421	07/10/2024	n/a
common	07/10/2025	restricted stock release	issuer			11881	07/10/2025	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the GLW Form 144 filing disclose?

The Form 144 for GLW discloses a shareholder’s intent to sell 30,000 common shares with an aggregate market value of $3,829,994.64. The notice provides details on broker, exchange, acquisition dates, and required representations about material information.

How many GLW shares are planned for sale and where will they trade?

The filing shows a plan to sell 30,000 common shares of GLW. The transaction is listed for execution through UBS Financial Services Inc. on the NYSE, with an approximate sale date of 02/09/2026, subject to market and trading conditions.

How were the GLW shares in the Form 144 acquired?

The shares in the Form 144 were acquired via restricted stock releases from the issuer. Acquisition dates are listed as 07/10/2024, 07/10/2025, and 01/15/2026, with each entry showing common stock received directly from the issuer as consideration.

What is the aggregate market value of the GLW shares to be sold?

The Form 144 lists an aggregate market value of $3,829,994.64 for the 30,000 common shares to be sold. This figure reflects the market value at the time of the notice and is tied to the disclosed planned sale amount.

Does the GLW Form 144 mention recent prior sales by the shareholder?

The form includes a section for securities sold during the past three months by the same person, but the provided excerpt does not show any completed entries there. The primary focus is on the planned sale of 30,000 shares disclosed in the notice.

What representation does the seller make about GLW’s information in the Form 144?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as part of signing the notice.